Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction

David Aguilar, Hicham Skali, Lemuel A. Moyé, Eldrin F. Lewis, J. Michael Gaziano, John D. Rutherford, L. Howard Hartley, Otelio S. Randall, Edward M. Geltman, Gervasio A. Lamas, Jean L. Rouleau, Marc A. Pfeffer, Scott D. Solomon

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

Objectives We assessed the influence of alcohol intake on the development of symptomatic heart failure (HF) in patients with left ventricular (LV) dysfunction after a myocardial infarction (MI). Background In contrast to protection from coronary heart disease, alcohol consumption has been linked to cardiodepressant effects and has been considered contraindicated in patients with HF. Methods The Survival And Ventricular Enlargement (SAVE) trial randomized 2,231 patients with a LV ejection fraction (EF) <40% following MI to an angiotensin-converting enzyme inhibitor or placebo. Patients were classified as nondrinkers, light-to-moderate drinkers (1 to 10 drinks/week), or heavy drinkers (>10 drinks/week) based on alcohol consumption reported at baseline. The primary outcome was hospitalization for HF or need for an open-label angiotensin-converting enzyme inhibitor. Analyses were repeated using alcohol consumption reported three months after MI. Results Nondrinkers were older and had more comorbidities than light-to-moderate and heavy drinkers. In univariate analyses, baseline light-to-moderate alcohol intake was associated with a lower incidence of HF compared with nondrinkers (hazard ratio [HR] 0.71; 95% confidence interval [CI] 0.57 to 0.87), whereas heavy drinking was not (HR 0.91; 95% CI 0.67 to 1.23). After adjustment for baseline differences, light-to-moderate baseline alcohol consumption no longer significantly influenced the development of HF (light-to-moderate drinkers HR 0.93; 95% CI 0.75 to 1.17; heavy drinkers HR 1.25; 95% CI 0.91 to 1.72). Alcohol consumption reported three months after the MI similarly did not modify the risk of adverse outcome. Conclusions In patients with LV dysfunction after an MI, light-to-moderate alcohol intake either at baseline or following MI did not alter the risk for the development of HF requiring hospitalization or an open-label angiotensin-converting enzyme inhibitor.

Original languageEnglish
Pages (from-to)2015-2021
Number of pages7
JournalJournal of the American College of Cardiology
Volume43
Issue number11
DOIs
StatePublished - Jun 2 2004

Keywords

  • CAD
  • CI
  • CV
  • HF
  • HR
  • LV
  • MI
  • NYHA
  • New York Heart Association
  • SAVE
  • SOLVD
  • Survival And Ventricular Enlargement trial
  • cardiovascular
  • confidence interval
  • coronary artery disease
  • hazard ratio
  • heart failure
  • left ventricular
  • myocardial infarction

Fingerprint Dive into the research topics of 'Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction'. Together they form a unique fingerprint.

  • Cite this

    Aguilar, D., Skali, H., Moyé, L. A., Lewis, E. F., Gaziano, J. M., Rutherford, J. D., Hartley, L. H., Randall, O. S., Geltman, E. M., Lamas, G. A., Rouleau, J. L., Pfeffer, M. A., & Solomon, S. D. (2004). Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. Journal of the American College of Cardiology, 43(11), 2015-2021. https://doi.org/10.1016/j.jacc.2004.01.042